Neuralstem Inc (CUR)

5.50
NASDAQ : Health Care
Prev Close 5.45
Day Low/High 5.35 / 5.55
52 Wk Low/High 2.47 / 10.61
Avg Volume 347.80K
Exchange NASDAQ
Shares Outstanding 11.03M
Market Cap 60.13M
EPS -3.00
Div & Yield N.A. (N.A)

Latest News

A Little Something for Everybody

A Little Something for Everybody

Positives seen for bulls and bears as traders shrug off risk.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Neuralstem Reports Third Quarter 2016 Results

Neuralstem Reports Third Quarter 2016 Results

Provides Business and Clinical Updates

Neuralstem Presents NSI-189 Preclinical Neurocognitive Benefits At The Radiation Research Society Annual Meeting

Neuralstem Presents NSI-189 Preclinical Neurocognitive Benefits At The Radiation Research Society Annual Meeting

NSI-189 Shows Reversal of Radiation-induced Cognitive Deficits

Neuralstem Presented NSI-189 Preclinical Data In Type 1 And Type 2 Diabetes At The Annual Meeting Of The Diabetic Neuropathy Study Group

Neuralstem Presented NSI-189 Preclinical Data In Type 1 And Type 2 Diabetes At The Annual Meeting Of The Diabetic Neuropathy Study Group

NSI-189 Shows Prevention and Reversal of Diabetic Neuropathies in Mice

Neuralstem Reports Second Quarter 2016 Results and Provides Business And Clinical Updates

Neuralstem Reports Second Quarter 2016 Results and Provides Business And Clinical Updates

Dr. Karl Johe Resigns from Board of Directors; Company Announces Creation of Scientific Policy Committee with Dr. Johe as Chairman

Neuralstem Announces NSI-189 Shows Enhancement Of Long-Term Potentiation In Vitro

Neuralstem Announces NSI-189 Shows Enhancement Of Long-Term Potentiation In Vitro

Data Contribute to Understanding NSI-189 Mechanism of Action

These 5 Stocks Under $10 Are About to Soar Higher

These 5 Stocks Under $10 Are About to Soar Higher

These under-$10 stocks are ready to move higher from current levels. Here's how to trade them from here.

Neuralstem To Raise $1.08 Million

Neuralstem To Raise $1.08 Million

Neuralstem Announces First Patient Enrolled In Phase 2 Clinical Trial In Major Depressive Disorder

Neuralstem Announces First Patient Enrolled In Phase 2 Clinical Trial In Major Depressive Disorder

Trial Efficacy Endpoints Include Reduction in Depression and Cognition Improvement

IIROC Trade Resumption - CUR

IIROC Trade Resumption - CUR

IIROC Trading Halt - CUR

IIROC Trading Halt - CUR